详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Troponin I, a risk factor indicating more severe pneumonia among patients with novel coronavirus infected pneumonia.

文献详情

资源类型：

Pubmed体系：

作者：

单位： [a]Department of Respiratory and Critical Care Medicine, Ruijin hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China [b]Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China [c]Tongji Hospital, Tongji Medical College of Hust, Tongji Medical College Huazhong University of Science & Technology, Shanghai, China [d]Department of pulmonary and critical care medicine, Zhongshan Hospital, Fudan University, Shanghai, China

出处：

DOI：

关键词： Novel coronavirus infected pneumonia Severe acute respiratory syndrome coronavirus 2 Troponin I Myocardial damage

摘要：

In December 2019, a novel communicable disease, novel coronavirus infected pneumonia (NCIP) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) broke out. We aimed to analyze the characteristics and severity of patients with myocardial damage in NCIP. We enrolled 215 adult patients with NCIP from January 2020 to February 2020. Outcomes were followed up until March 1st, 2020. 28.37% of the total patients showed increased level of TnI (> 0.040 ng/ml). Patients were older and had more cardiovascular complications in increased TnI group. Higher CRP, NT-proBNP, lower immune CD3, CD4 and CD8 cell account and more involved lobes detected by CT scan in the lung were observed in increased TnI group. Patients with elevated TnI had higher CURB-65 scores and were more likely given glucocorticoid therapy and mechanical ventilation than patients in normal TnI group. Markers of cardiomyocyte injury were elevated not least in elderly males with pre-existing cardiovascular disease. Patients with elevated TnI presented more severe situation, leading to multiple organ dysfunctions, which appeared as a pivotal feature of patients with NCIP that requires attention by clinicians in order to provide necessary treatment as soon as possible and improve patients' outcomes. © 2020 Published by Elsevier Ltd on behalf of British Infection Association.

基金：

语种：

PubmedID：

第一作者：

第一作者单位： [a]Department of Respiratory and Critical Care Medicine, Ruijin hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China [b]Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China

共同第一作者：

通讯作者：

通讯机构： [a]Department of Respiratory and Critical Care Medicine, Ruijin hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China [b]Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China [*1]Department of Respiratory and Critical CareMedicine, Ruijin Hospital, Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

Troponin I, a risk factor indicating more severe pneumonia among patients with novel coronavirus infected pneumonia.

文献详情

相关文献